TrialJAMA oncology2017

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study.

Thomas Powles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.